When should I have a bone density scan?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
The US Preventive Services Task Force recommends bone density screening for all women aged 65 and older, and for postmenopausal women under 65 who are at increased risk, both Grade B. The International Society for Clinical Densitometry adds men aged 70 and older. A T-score of minus 2.5 or below at the spine or hip diagnoses osteoporosis.
A bone density scan, or DXA, measures bone mineral density at the spine and hip and reports it as a T-score. It is the test that identifies osteoporosis before a fracture rather than after one, which matters because the first symptom of osteoporosis is usually a broken bone. Two sets of recommendations govern who should have one: the US Preventive Services Task Force for population screening, and the International Society for Clinical Densitometry for clinical indications.
Who should be screened
In its 2025 recommendation, the US Preventive Services Task Force recommends screening for osteoporosis to prevent osteoporotic fractures in women aged 65 years or older, a Grade B recommendation, and in postmenopausal women younger than 65 who are at increased risk, also Grade B. For men, the Task Force concluded that current evidence is insufficient to assess the balance of benefits and harms, a Grade I statement, which means clinical judgement rather than a recommendation against testing. The International Society for Clinical Densitometry recommends testing women aged 65 and older, men aged 70 and older, and younger adults with risk factors.
What counts as increased risk before 65
The situations that move testing earlier are specific: a fracture after the age of 50 from a fall at standing height, long term glucocorticoid use, early menopause including surgical menopause, low body weight, height loss, rheumatoid arthritis, coeliac disease or other malabsorption, hyperparathyroidism, hyperthyroidism, and prior bariatric surgery. Aromatase inhibitors for breast cancer and androgen deprivation therapy for prostate cancer both accelerate bone loss and are their own indication.
How to read the result
The Bone Health and Osteoporosis Foundation sets out the categories used for postmenopausal women and men aged 50 and over: a T-score of minus 1.0 or above is normal, between minus 1.0 and minus 2.5 is low bone mass, and "a T-score of -2.5 or below is a diagnosis of osteoporosis". The International Society for Clinical Densitometry advises measuring bone mineral density at both the posteroanterior spine and the hip in all patients, and using Z-scores rather than T-scores in premenopausal women and men under 50.
| Group | Recommendation | Source |
|---|---|---|
| Women 65 and older | Screen, Grade B | USPSTF 2025 |
| Postmenopausal women under 65 at increased risk | Screen, Grade B | USPSTF 2025 |
| Men | Evidence insufficient, Grade I | USPSTF 2025 |
| Men 70 and older | Test | ISCD Adult Official Positions |
| Anyone with a fracture after age 50 | Test | Bone Health and Osteoporosis Foundation |
If you are a postmenopausal woman under 65, ask for a fracture risk assessment rather than assuming you must wait until 65. If you have had a broken bone from a minor fall after the age of 50, that is an indication for a scan now, whatever your age or sex. Ask for spine and hip together, and keep the report, since future scans are compared against it.
The clinical detail
Interpretation follows the site and the population. The International Society for Clinical Densitometry recommends measuring the posteroanterior spine and hip in all patients, reserving forearm measurement for cases where spine or hip cannot be measured or interpreted, in hyperparathyroidism, and in patients above the table weight limit. T-scores are used for postmenopausal women and men aged 50 and over; Z-scores are used for premenopausal women, men under 50 and children.
Bone density is one input to fracture risk rather than the whole of it. FRAX combines clinical risk factors with femoral neck bone mineral density to estimate 10-year fracture probability, and the USPSTF notes that risk assessment may be used with or instead of bone mineral density in younger postmenopausal women. Secondary causes, including vitamin D deficiency, coeliac disease, hyperparathyroidism and hyperthyroidism, are assessed before treatment starts.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Osteoporosis to Prevent Fractures: Screening (2025). US Preventive Services Task Force
- Adult Official Positions. International Society for Clinical Densitometry
- Bone Density Exam and Testing. Bone Health and Osteoporosis Foundation
- Bone Density Scan. MedlinePlus, National Library of Medicine
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.